ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 12 | -100.0% | 0.00% | – |
| Q1 2022 | $198,000 | -37.9% | 303,297 | +3.7% | 0.00% | – |
| Q4 2021 | $319,000 | +27.6% | 292,518 | +112.4% | 0.00% | – |
| Q3 2021 | $250,000 | -27.5% | 137,750 | +5.5% | 0.00% | – |
| Q2 2021 | $345,000 | -39.9% | 130,514 | -18.2% | 0.00% | – |
| Q1 2021 | $574,000 | -27.4% | 159,494 | -49.2% | 0.00% | – |
| Q4 2020 | $791,000 | -3.8% | 314,210 | -3.7% | 0.00% | -100.0% |
| Q3 2020 | $822,000 | -18.7% | 326,123 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $1,011,000 | +81.8% | 308,218 | +35.8% | 0.00% | – |
| Q1 2020 | $556,000 | -41.9% | 227,028 | +11.8% | 0.00% | -100.0% |
| Q4 2019 | $957,000 | +10.4% | 203,031 | +0.2% | 0.00% | 0.0% |
| Q3 2019 | $867,000 | +46.7% | 202,603 | +99.9% | 0.00% | 0.0% |
| Q2 2019 | $591,000 | +70.8% | 101,375 | +12.4% | 0.00% | – |
| Q1 2019 | $346,000 | +111.0% | 90,203 | +2.6% | 0.00% | – |
| Q4 2018 | $164,000 | -30.8% | 87,898 | +18.7% | 0.00% | – |
| Q3 2018 | $237,000 | -29.9% | 74,079 | -33.7% | 0.00% | – |
| Q2 2018 | $338,000 | -35.9% | 111,723 | -17.0% | 0.00% | – |
| Q1 2018 | $527,000 | +22.0% | 134,561 | +29.0% | 0.00% | – |
| Q4 2017 | $432,000 | -57.3% | 104,316 | -36.7% | 0.00% | -100.0% |
| Q3 2017 | $1,011,000 | +33.9% | 164,773 | +35.8% | 0.00% | 0.0% |
| Q2 2017 | $755,000 | -34.8% | 121,326 | -33.6% | 0.00% | 0.0% |
| Q1 2017 | $1,158,000 | +51.2% | 182,699 | +27.7% | 0.00% | 0.0% |
| Q4 2016 | $766,000 | +29.2% | 143,102 | +35.9% | 0.00% | 0.0% |
| Q3 2016 | $593,000 | -5.0% | 105,290 | -7.4% | 0.00% | 0.0% |
| Q2 2016 | $624,000 | -58.0% | 113,679 | -43.1% | 0.00% | -50.0% |
| Q1 2016 | $1,484,000 | +10.7% | 199,825 | +23.9% | 0.00% | 0.0% |
| Q4 2015 | $1,340,000 | -74.9% | 161,281 | -72.8% | 0.00% | -71.4% |
| Q3 2015 | $5,343,000 | +103.2% | 592,838 | +170.5% | 0.01% | +133.3% |
| Q2 2015 | $2,630,000 | +254.0% | 219,173 | +217.9% | 0.00% | +200.0% |
| Q1 2015 | $743,000 | +324.6% | 68,940 | +100.3% | 0.00% | – |
| Q4 2014 | $175,000 | -8.4% | 34,424 | -52.7% | 0.00% | – |
| Q3 2014 | $191,000 | -46.6% | 72,781 | -17.8% | 0.00% | – |
| Q2 2014 | $358,000 | -35.5% | 88,567 | -27.0% | 0.00% | -100.0% |
| Q1 2014 | $555,000 | +55.0% | 121,287 | +47.3% | 0.00% | – |
| Q4 2013 | $358,000 | +173.3% | 82,365 | +147.9% | 0.00% | – |
| Q3 2013 | $131,000 | +28.4% | 33,230 | -31.1% | 0.00% | – |
| Q2 2013 | $102,000 | -46.6% | 48,262 | -53.8% | 0.00% | – |
| Q1 2013 | $191,000 | – | 104,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |